Translation of our caveolae targeting strategy towards research and clinical utility will require considerable efforts to create new retargeted effector (therapeutic) and imaging agents, as well as to define which are amenable to more effective in vivo delivery through the caveolae pumping system.  To maximize the potential of translating our science into important medical advances that benefits patients, we are actively seeking highly collaborative relationships with industry.  

Please contact a Peggy Faix, Ph.D.  at pfaix@cavatar-sd.com